S

SOPH

SOPHiA GENETICS SA Ordinary Shares
$7.06
Current Price
AI analysis
Read what the AI thinks of SOPHiA GENETICS SA Ordinary Shares in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app

Key figures

Dividend per share
—
Yield
—
EPS
-$1.15
P/E
—
Data as of Oct 1
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings
Expected EPS: -$0.19
Nov 10

Posts

No posts about SOPH yet.

About SOPHiA GENETICS SA Ordinary Shares

SOPHiA GENETICS is a Swiss-founded software company that sells a cloud platform to hospitals and labs. The platform analyzes genetic and medical data so doctors can diagnose diseases such as cancer and choose treatments. It earns money from subscriptions and usage fees that labs and hospitals pay to run their tests through the platform.

Add SOPH to your watchlist

Add SOPH to your watchlist.
Scan with your iPhone camera: this page opens in the app.
  • Its AI analysis
  • Every story about it, live
  • An alert when a wallet trades it
Download on the App Store